118555-99-0

Basic information

• Product Name: 4-(2,4-DIMETHOXYBENZYLIDENE)-5-OXO-2-PHENYLOXAZOLINE
• Synonyms: 4-(2,4-DIMETHOXYBENZYLIDENE)-5-OXO-2-PHENYLOXAZOLINE;4-(2,4-DdiMethoxybenzylidene)-2-phenyloxazol-5(4H)-one;4-(2,4-DIMETHOXYBENZYLIDENE)-2-PHENYL-2-OXAZOLIN-5-ONE
• CAS NO: 118555-99-0
• Molecular Formula: C₁₈H₁₅NO₄
• Molecular Weight: 309.32
• Mol File: 118555-99-0.mol

Chemical Properties

• Melting Point: 169-180 °C(Solv: ethanol (64-17-5))
• Boiling Point: 470.8±55.0 °C(Predicted)
• Appearance: /
• Density: 1.20±0.1 g/cm3(Predicted)
• PKA: -0.43±0.20(Predicted)
• CAS DataBase Reference: 4-(2,4-DIMETHOXYBENZYLIDENE)-5-OXO-2-PHENYLOXAZOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2,4-DIMETHOXYBENZYLIDENE)-5-OXO-2-PHENYLOXAZOLINE(118555-99-0)
• EPA Substance Registry System: 4-(2,4-DIMETHOXYBENZYLIDENE)-5-OXO-2-PHENYLOXAZOLINE(118555-99-0)

Safety Data

• Hazardous Substances Data: 118555-99-0(Hazardous Substances Data)

Upstream product

• 495-69-2 Hippuric Acid 
• 613-45-6 2,4-Dimethoxybenzaldehyde 

Downstream Products

• 1855-30-7 1-(2,4-dihydroxyphenyl)-2-(2,4-dimethoxyphenyl)ethanone 
• 1891-01-6 3-(2,4-dimethoxyphenyl)-7-hydroxy-4H-chromen-4-one 
• 1890-99-9 7-hydroxy-3-(2-hydroxy-4-methoxyphenyl)-4H-chromen-4-one 
• 55954-25-1 methyl 2-(2,4-dimethoxyphenyl)acetate 
• 119872-11-6 (Z)-2-benzoylamino-3-(2,4-dimethoxyphenyl)acrylic acid 
• 6496-89-5 2,4-dimethoxyphenylacetic acid 
• 139109-55-0 3-(2,4-dimethoxy-phenyl)-2-hydroxyimino-propionic acid 
• 65-85-0 benzoic acid 
• 91144-06-8 (2,4-dimethoxy-phenyl)-pyruvic acid 
• 7149-96-4 (+/-)-2-benzoylamino-3-(2,4-dimethoxyphenyl)propionic acid 
• 872832-52-5 (+/-)-N-[2-(2,4-dimethoxyphenyl)-1-methoxycarbamoylethyl]benzamide 
• 130895-82-8 α-methoxy-2-(4-methoxyphenyl)acetic acid 

Relevant articles and documents

New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof

PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.

NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR

Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.

Development of a model system for the study of long distance electron transfer in peptides

We have designed and synthesized a peptide model in which stepwise electron transfer (ET) through amino acid side chains could be observed. An injection system, which generates an electron hole upon laser irradiation, was connected directly to the aromati

Biosynthesis of the A/B/C/D-Ring System of the Rotenoid Amorphigenin by Amorpha fruticosa Seedlings

With phenylalanine as the starting point, the biosynthesis of the characteristic rotenoid A/B/C/D-ring system of amorphigenin is studied using Amorpha fruticosa seedlings.The course of the biosynthesis can be divided into four phases represented by the bordered and interconnecting Schemes 1, 3, 6 and 7 which summarise the Chalcone-Flavanone Phase, the Flavanone-Isoflavone Phase, the Hydroxylation/Methoxylation Phase and the Rotenoid Phase.By using an INADEQUATE NMR experiment involving the administration of acetate, the type of folding forming ring-D isdemonstrated by 13C-13C coupling and is interpreted as involving a polyketide containing a glutaconate segment which cyclises by a Claisen condensation.The resulting chalcone is cyclised, enzymically and stereospecifically, to 4',7-dihydroxyflavanone.The latter flavanone undergoes aryl migration, in a manner similar to that found in isoflavone biosynthesis, to give 7-hydroxy-4'-methoxyisoflavone.Possible mechanisms for the flavanone-isoflavone rearrangement are discussed, including a proposal that the initiating step involves attack on ring-A and is similar to the first stage of the aromatic hydroxylation of tyrosine to dopa.Although possessing no 4'-hydroxy group in ring-A, the mechanism is also applicable to the recently discovered rotenoids of the Boerhaavia and Iris type, and it provides an explanation for the biogenesis of natural spirobenzocyclobutanes from dihydroeucominoids.Six suitably substituted isoflavonoids labelled with 13C or 3H are synthesized and are used to show that the next hydroxylation (and probably methylation) involves C-3' rather than C-2' in 7-hydroxy-4'-methoxyisoflavone.Whilst the methylations involveS-adenosylmethionine, the hydroxylating enzymes are probably very similar to the flavanone-isoflavone-rearranging enzyme.The closure of ring-B to form finally the rotenoid system probably involves conjugate addition of a methoxyl radical.Prenylation and oxidative modifications are characteristically late-stage processes.

PHASEOLOIDIN, A HOMOGENTISIC ACID GLUCOSIDE FROM ENTADA PHASEOLOIDES

The structure of phaseoloidine isolated from the seeds of Entada phaseolides has been determined as homogentisic acid 2-O-β-D-glucopyranoside by chemical and spectral means.